Plamed Asia is a healthcare fieldwork specialist focused on providing services to market research companies and consulting firms in the medical industry throughout Asia. The company is engaged in conducting interviews and providing access to healthcare professionals.

Plamed Asia

Plamed Asia | 354 followers on LinkedIn. Your one-stop source for seamless, high-quality healthcare fieldwork services in Asia. | Plamed Asia is your one-stop source for seamless, high-quality healthcare fieldwork services in Asia.

Please visit our website to learn more about our services.

Associate Director at Plamed Asia

Yuriko Takahashi

The Plamed Asia team traded laptops for fishing rods at a scenic Tokyo spot for an unforgettable team-building experience. 😎 First-time anglers and seasoned pros gathered by the water's edge, we cheer the hard work and achievement 🎉 with drumrolls and the surreal taste of sashimi. 360° surrounded by cherry blossoms 🌸 , what a lovely way to celebrate a magnificent spring day with our teammates! #PlamedAsia #TeamBonding #Teamwork #Collaboration #Healthcare #MedicalMarketResearch

On the eve of Lunar New Year, bid farewell to the old and usher in the new! 😀 Plamed Asia joins you in looking forward to the wonderful Year of the Dragon! Warmest blessings from our team in Hong Kong and China "Gong Xi Fa Cai! 恭喜發財!"

Our capability in Japan keeps expanding! Multiple CAR-T cell therapies have been approved in Japan, and several more will come soon. We are excited to share the details of the CAR-T landscape mapping project with 300 online surveys and 20 WATI interviews (including 14 treaters of CAR-T individual facilities).Our research last year aimed to map the current CAR-T cell therapy landscape and identify future opportunities in clinical practice. Check out the online portion of the project and stay tuned for the outcome of the qualitative part of this interesting project. Plamed Asia conducts healthcare projects in Japan, China, Korea and many other Asian markets. Contact our team at inquiry@plamedasia.com to discuss your proposal.

This is the festive season to express our heartfelt gratitude! The Plamed Asia team thanks our clients & industry colleagues for the fruitful collaborations and synergy in pursuing mutual goals and values. We are immensely grateful to our HCP panels, who trusted and supported us in completing many meaningful studies in Asia despite their busy work schedules. May your holidays be filled with joy, peace and precious moments with loved ones. We look forward to 2024, continue to be an essential part of your journey and achieve even more new milestones together! #Happyholidays #Happynewyear #hcps #Healthcare #Research #MedicalMarketResearch

We are thrilled to share the fascinating findings from a comprehensive study conducted in China (n=1000 HCPs), shedding light on the awareness and sales rep's visits of 51 leading international and domestic pharmaceutical companies. The study aimed to explore the dynamics between pharmaceutical representatives and healthcare providers, providing valuable insights into the evolving landscape of the Chinese pharmaceutical industry. Reach out to discuss its further implications: inquiry@plamedasia.com

Google Maps

Amazon

City of Tokyo Companies With Less Than $10M in Revenue

Market Research Companies With More Than $1M in Revenue

Tokyo Companies With Less Than $500M in Revenue (Top 10K)

Asia-Pacific (APAC) Analytics Companies

Plamed provides a survey on medical care for doctors members and is used for market analysis and academic research.

Tokyo

Japan

Asia

Plamed

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 18, 2024 2:36 AM	afa1bb30
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 18, 2024 2:36 AM	094b885e
crunchbase trigger	general	Nov 18, 2024 2:36 AM	0f24ba1c
crunchbase profile	general	Nov 18, 2024 3:03 AM	b0aef8c0
li profile	general	Nov 18, 2024 2:36 AM	f48b2df4
translate crunchbase fundingrounds	general	Nov 18, 2024 3:21 AM	e768210a
peers	general	Nov 18, 2024 2:36 AM	d028feff
news basic	general	Nov 18, 2024 2:36 AM	ee7b9033
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

PLAM

COM:PLAMEDASIA

Plamed Asia